PCORI’s authorizing law, as amended by the 2019 reauthorizing legislation, includes a provision requiring PCORI-funded research to consider, as appropriate, the full range of outcomes data, including potential burdens and economic impacts. Consistent with this mandate, PCORI has adopted Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research (PCORI Principles).
Thus, PCORI is particularly interested in applications under the Engagement Award: Stakeholder Convening Support funding announcement for convenings focused on defining appropriate and relevant burdens and economic impact data, identifying sources of data or gaps in data, and opportunities to advance the rigor and standards when conducting research that considers the full range of outcomes data, consistent with the PCORI Principles. Advancing the fundamental basis of data collection and methodology in this area is critical to ensuring that PCORI-funded research is appropriately considering the full range of outcomes data.
Please Note: PCORI reminds prospective applicants that special areas of interest exist to encourage submissions on a topic, not to limit submissions to that topic only. PCORI welcomes Engagement Award: Stakeholder Convening Support Letters of Intent (LOIs) for convenings on all topics with a clear focus on and commitment to patient-centered outcomes research/comparative effectiveness research (PCOR/CER) that falls within the guidelines of the program.
PCORI is seeking applications from organizations engaged in advancing patient-centered care, specifically as it relates to defining appropriate and relevant patient-centered burden and economic impact data and/or refining methodologies to capture and consider patient-centered perspectives and preferences in PCOR/CER. PCORI is particularly interested in applications from organizations seeking to build collaborations or partnerships with diverse stakeholders to advance consideration of patient-centered burdens and economic impacts in PCOR/CER and/or other healthcare decision making.
Please note that while PCORI’s authorizing law, as amended by the 2019 reauthorization legislation, does direct PCORI-funded research to capture, as appropriate, potential burdens and economic impacts, PCORI’s authorizing law includes a prohibition on the development or employment of dollars-per-quality-adjusted life year (QALY) thresholds. Additionally, PCORI’s authorizing law, as amended, prohibits PCORI from mandating coverage, reimbursement, or other policies for any public or private payer and prohibits PCORI-funded research from including practice guidelines, coverage recommendations, payment, or policy recommendations. Consistent with these prohibitions, PCORI’s authorizing law, as amended by the 2019 reauthorizing legislation, focuses on comparative clinical effectiveness research and PCORI does not fund the conduct of cost-effectiveness analysis (CEA).
Applications focused on QALY methods development or employment, development of practice guidelines, coverage recommendations, payment or policy recommendations, or the conduct of cost-effectiveness analysis (CEA), will be considered nonresponsive to this funding announcement and will be declined. PCORI appreciates the importance of such discussions but is solely interested through this funding opportunity in applications proposing exploration of innovative, patient-centered approaches to considering the full range of outcomes data.
For organizations considering submitting an LOI for an Engagement Award: Stakeholder Convening Support focused on topics related to the full range of outcomes data, please review PCORI’s Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research for additional context and implementation goals. We strongly encourage applicants for this special area of interest to consider requesting a program fit call while developing the LOI. Questions and requests for a program fit call may be directed to [email protected].
Posted: August 2, 2021